Free Trial
NASDAQ:INVO

INVO Bioscience Q3 2023 Earnings Report

INVO Bioscience logo
$1.65 -0.03 (-1.79%)
As of 05/27/2025

INVO Bioscience EPS Results

Actual EPS
-$0.70
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

INVO Bioscience Revenue Results

Actual Revenue
$0.98 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

INVO Bioscience Announcement Details

Quarter
Q3 2023
Time
N/A
Conference Call Date
Monday, November 13, 2023
Conference Call Time
4:00PM ET

Earnings Documents

INVO Bioscience Earnings Headlines

White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington.
See More INVO Bioscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like INVO Bioscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on INVO Bioscience and other key companies, straight to your email.

About INVO Bioscience

INVO Bioscience (NASDAQ:INVO), together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

View INVO Bioscience Profile

More Earnings Resources from MarketBeat